The list of the top 500 listed companies in China was released, and 15 pharmaceutical companies were on the list!

1861689289942895

Source: Fortune official website

On July 12th, Fortune released the list of the top 500 listed companies in China in 2023, considering the performance and achievements of the largest listed company in China in the world in the past year. The total revenue of the 500 listed companies in China reached 65.8 trillion yuan. The annual revenue threshold of listed companies is close to 23.7 billion yuan. The total net profit of the 500 listed companies was 4.7 trillion yuan, and the total profit of the top ten companies in the profit list exceeded 2 trillion yuan last year, accounting for about 43% of the total profits of the listed companies.　

Among them, 15 pharmaceutical companies are on the list.　

Compared with 2022, the ranking of the top three pharmaceutical companies remains unchanged. The top three pharmaceutical companies in this year’s list are: Sinopharm Holdings Co., Ltd. (revenue of 552.15 billion yuan), Shanghai Pharmaceutical Group Co., Ltd. (revenue of 231.98 billion yuan) and China Resources Pharmaceutical Group Co., Ltd. (revenue of 218.25 billion yuan).

Compared with 2022, there are 2 pharmaceutical companies with the same ranking position, and Sinopharm Holdings ranks 24th, with revenue of 552.15 billion yuan. Baiyunshan Pharmaceutical Group, ranked 195th, with revenue of 70.79 billion yuan. A total of 10 pharmaceutical companies rose in the ranking, ranking the top three pharmaceutical companies, and Chongqing Zhifei Bio rose the most, ranking 59 places and ranking 332; Nanjing medicine ranks 24 places, ranking 257; The ranking of East China Medicine rose by 23 places, ranking 334th.

The specific rankings are as follows:

Fortune Top 500 Listed Companies in China in 2023 (Pharmaceutical Companies)

95431689289942974